Cargando…

P1101: A PROSPECTIVE TRIAL OF A NOVEL RECOMBINANT HUMANIZEDANTI-INTERLEUKIN-6 RECEPTOR MONOCLONAL ANTIBODY INJECTION(VDJ001) IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: THE PRELIMINARY RESULTS

Detalles Bibliográficos
Autores principales: Zhang, Lu, Dong, Yujun, Gong, Xiao-Ming, Zhang, Xiao-Rui, MA, Rong, Cheng, Jian-Wei, Zhang, Jun, LI, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430902/
http://dx.doi.org/10.1097/01.HS9.0000971300.41514.8a
_version_ 1785091070762156032
author Zhang, Lu
Dong, Yujun
Gong, Xiao-Ming
Zhang, Xiao-Rui
MA, Rong
Cheng, Jian-Wei
Zhang, Jun
LI, Jian
author_facet Zhang, Lu
Dong, Yujun
Gong, Xiao-Ming
Zhang, Xiao-Rui
MA, Rong
Cheng, Jian-Wei
Zhang, Jun
LI, Jian
author_sort Zhang, Lu
collection PubMed
description
format Online
Article
Text
id pubmed-10430902
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104309022023-08-17 P1101: A PROSPECTIVE TRIAL OF A NOVEL RECOMBINANT HUMANIZEDANTI-INTERLEUKIN-6 RECEPTOR MONOCLONAL ANTIBODY INJECTION(VDJ001) IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: THE PRELIMINARY RESULTS Zhang, Lu Dong, Yujun Gong, Xiao-Ming Zhang, Xiao-Rui MA, Rong Cheng, Jian-Wei Zhang, Jun LI, Jian Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430902/ http://dx.doi.org/10.1097/01.HS9.0000971300.41514.8a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Zhang, Lu
Dong, Yujun
Gong, Xiao-Ming
Zhang, Xiao-Rui
MA, Rong
Cheng, Jian-Wei
Zhang, Jun
LI, Jian
P1101: A PROSPECTIVE TRIAL OF A NOVEL RECOMBINANT HUMANIZEDANTI-INTERLEUKIN-6 RECEPTOR MONOCLONAL ANTIBODY INJECTION(VDJ001) IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: THE PRELIMINARY RESULTS
title P1101: A PROSPECTIVE TRIAL OF A NOVEL RECOMBINANT HUMANIZEDANTI-INTERLEUKIN-6 RECEPTOR MONOCLONAL ANTIBODY INJECTION(VDJ001) IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: THE PRELIMINARY RESULTS
title_full P1101: A PROSPECTIVE TRIAL OF A NOVEL RECOMBINANT HUMANIZEDANTI-INTERLEUKIN-6 RECEPTOR MONOCLONAL ANTIBODY INJECTION(VDJ001) IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: THE PRELIMINARY RESULTS
title_fullStr P1101: A PROSPECTIVE TRIAL OF A NOVEL RECOMBINANT HUMANIZEDANTI-INTERLEUKIN-6 RECEPTOR MONOCLONAL ANTIBODY INJECTION(VDJ001) IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: THE PRELIMINARY RESULTS
title_full_unstemmed P1101: A PROSPECTIVE TRIAL OF A NOVEL RECOMBINANT HUMANIZEDANTI-INTERLEUKIN-6 RECEPTOR MONOCLONAL ANTIBODY INJECTION(VDJ001) IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: THE PRELIMINARY RESULTS
title_short P1101: A PROSPECTIVE TRIAL OF A NOVEL RECOMBINANT HUMANIZEDANTI-INTERLEUKIN-6 RECEPTOR MONOCLONAL ANTIBODY INJECTION(VDJ001) IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: THE PRELIMINARY RESULTS
title_sort p1101: a prospective trial of a novel recombinant humanizedanti-interleukin-6 receptor monoclonal antibody injection(vdj001) in idiopathic multicentric castleman disease: the preliminary results
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430902/
http://dx.doi.org/10.1097/01.HS9.0000971300.41514.8a
work_keys_str_mv AT zhanglu p1101aprospectivetrialofanovelrecombinanthumanizedantiinterleukin6receptormonoclonalantibodyinjectionvdj001inidiopathicmulticentriccastlemandiseasethepreliminaryresults
AT dongyujun p1101aprospectivetrialofanovelrecombinanthumanizedantiinterleukin6receptormonoclonalantibodyinjectionvdj001inidiopathicmulticentriccastlemandiseasethepreliminaryresults
AT gongxiaoming p1101aprospectivetrialofanovelrecombinanthumanizedantiinterleukin6receptormonoclonalantibodyinjectionvdj001inidiopathicmulticentriccastlemandiseasethepreliminaryresults
AT zhangxiaorui p1101aprospectivetrialofanovelrecombinanthumanizedantiinterleukin6receptormonoclonalantibodyinjectionvdj001inidiopathicmulticentriccastlemandiseasethepreliminaryresults
AT marong p1101aprospectivetrialofanovelrecombinanthumanizedantiinterleukin6receptormonoclonalantibodyinjectionvdj001inidiopathicmulticentriccastlemandiseasethepreliminaryresults
AT chengjianwei p1101aprospectivetrialofanovelrecombinanthumanizedantiinterleukin6receptormonoclonalantibodyinjectionvdj001inidiopathicmulticentriccastlemandiseasethepreliminaryresults
AT zhangjun p1101aprospectivetrialofanovelrecombinanthumanizedantiinterleukin6receptormonoclonalantibodyinjectionvdj001inidiopathicmulticentriccastlemandiseasethepreliminaryresults
AT lijian p1101aprospectivetrialofanovelrecombinanthumanizedantiinterleukin6receptormonoclonalantibodyinjectionvdj001inidiopathicmulticentriccastlemandiseasethepreliminaryresults